# Neuralink — Healthcare Investment Intelligence

> medical_device · Series H. MedFuel Intel profile as of 2026-06-12.

Neuralink is developing implantable brain-computer interfaces (BCIs) with a small neural chip called 'the Link' that detects neuron activity at 1,024 sites and transmits signals wirelessly via Bluetooth. The company received FDA approval for human trials in May 2023 and implanted its first patient in January 2024, enabling quadriplegic Noland Arbaugh to control devices with his mind.

## Key facts (as of 2026-06-12)
- Sector: medical_device
- Stage: Series H
- Website: https://neuralink.com

## MedFuel assessment
- Intelligence score: 0/100
- Analyses: 0
- Sentiment trend: stable

---
Source: MedFuel Intel — https://medfuelintel.com/company/neuralink-22. Figures reflect MedFuel's analysis; verify against primary sources (SEC, FDA, ClinicalTrials.gov) before any investment decision.